These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36229818)

  • 1. Stakeholders analysis of COVID-19 management and control: a case of Iran.
    Mohamadian M; Nasiri T; Bahadori M; Jalilian H
    BMC Public Health; 2022 Oct; 22(1):1909. PubMed ID: 36229818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/AIDS policy-making in Iran: A stakeholder analysis.
    Khodayari-Zarnaq R; Ravaghi H; Mosaddegh-Rad AM; Jalilian H; Bazyar M
    Int J Health Plann Manage; 2021 Nov; 36(6):2351-2365. PubMed ID: 34455639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing of physical rehabilitation services in Iran: a stakeholder and social network analysis.
    Shahabi S; Ahmadi Teymourlouy A; Shabaninejad H; Kamali M; Lankarani KB
    BMC Health Serv Res; 2020 Jul; 20(1):599. PubMed ID: 32611339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholder analysis of childhood obesity prevention policies in Iran.
    Taghizadeh S; Zarnag RK; Farhangi MA
    Arch Public Health; 2021 Mar; 79(1):36. PubMed ID: 33731204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.
    Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Mousavi SM; Delpasand M
    Health Res Policy Syst; 2021 Dec; 19(1):150. PubMed ID: 34949207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eliminating Healthcare-Associated Infections in Iran: A Qualitative Study to Explore Stakeholders' Views.
    Esfandiari A; Salari H; Rashidian A; Masoumi Asl H; Rahimi Foroushani A; Akbari Sari A
    Int J Health Policy Manag; 2018 Jan; 7(1):27-34. PubMed ID: 29325400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explaining the role and responsibilities of the National Anti-Coronavirus Headquarters in prevention and emergency response to pandemics in the workplace: a qualitative study on COVID-19 experience in Iran.
    Khosravi Y; Farshad AA; Gh MM; Faghihi M; Ezati E; Hassanzadeh-Rangi N; Yarmohammadi S
    BMC Health Serv Res; 2023 Feb; 23(1):137. PubMed ID: 36759805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Data Utilization in North Carolina: Qualitative Analysis of Stakeholder Experiences.
    Patterson JR; Shaw D; Thomas SR; Hayes JA; Daley CR; Knight S; Aikat J; Mieczkowska JO; Ahalt SC; Krishnamurthy AK
    JMIR Public Health Surveill; 2021 Sep; 7(9):e29310. PubMed ID: 34298500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide.
    Newlands R; Bruhn H; Díaz MR; Lip G; Anderson LA; Ramsay C
    BMC Health Serv Res; 2024 May; 24(1):569. PubMed ID: 38698386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying the non-governmental organizations' activities and challenges in response to the COVID-19 pandemic in Iran.
    Sayarifard A; Nazari M; Rajabi F; Ghadirian L; Sajadi HS
    BMC Public Health; 2022 Apr; 22(1):704. PubMed ID: 35399049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated early childhood development policy in Iran: a stakeholder analysis.
    Atashbahar O; Sari AA; Takian A; Olyaeemanesh A; Mohamadi E; Barakati SH
    BMC Health Serv Res; 2021 Sep; 21(1):971. PubMed ID: 34526031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of the COVID-19 rapid response system to public health policymaking in Islamic Republic of Iran.
    Akbari-Sari A; Ahmadnezhad E; Abdi Z; Riazi-Isfahani S; Saffarpour S
    East Mediterr Health J; 2023 Jul; 29(7):570-574. PubMed ID: 37553745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding conflicts of interest in rational drug prescription in a developing country: A stakeholder analysis, healthcare guidelines and ethical public health issues.
    Moradi F; Bazyar M; Soroush A; Seyedin H; Soleymani F; Etemadi M; Ezadi S; Salimi M; Behzadifar M; Martini M; Hussain R
    J Prev Med Hyg; 2023 Sep; 64(3):E358-E366. PubMed ID: 38126000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the COVID-19 pandemic on the provision of HIV/AIDS-related services in Iran: a qualitative study.
    Jaafari Z; Mirzaei H; Moradi Y; Nasiri N; Mehmandoost S; Khezri M; Tavakoli F; Abbaszadeh S; Sharifi H
    BMC Health Serv Res; 2023 May; 23(1):430. PubMed ID: 37138294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of malnutrition among children under 5 years old in Iran: A policy analysis.
    Mohseni M; Aryankhesal A; Kalantari N
    PLoS One; 2019; 14(3):e0213136. PubMed ID: 30845189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholder analysis of Iran's health insurance system.
    Heydari M; Seyedin H; Jafari M; Dehnavieh R
    J Educ Health Promot; 2018; 7():135. PubMed ID: 30505863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying social perceptions of people ignoring COVID-19 warnings: a qualitative study in Iran.
    Halvaiepour Z; Nosratabadi M
    BMC Res Notes; 2021 Sep; 14(1):382. PubMed ID: 34579776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Main actors in the new population policy with a growing trend in Iran: a stakeholder analysis.
    Jafari H; Pourreza A; Kabiri N; Khodyari-Zarnaq R
    J Health Popul Nutr; 2022 Dec; 41(1):57. PubMed ID: 36510303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring adequate health financing to prevent and control the COVID-19 in Iran.
    Behzadifar M; Ghanbari MK; Bakhtiari A; Behzadifar M; Bragazzi NL
    Int J Equity Health; 2020 May; 19(1):61. PubMed ID: 32375787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.